Error: Could not add to watchlist. X

Repligen Corp

+ Watchlist
RGEN:US
NASDAQ GS
41.76
USD
1.72
4.30%
As of 16:30:00 ET on 07/06/2015.
Open
39.81
Day Range
39.66 - 41.90
Volume
204,796
Previous Close
40.04
52Wk Range
18.23 - 42.48
1 Yr Return
75.61%
Current P/E Ratio (TTM)
156.29
Earnings per Share (USD) (TTM)
0.27
Market Cap (b USD)
1.367
Shares Outstanding (m)
32.852
Price/Sales (TTM)
20.02
Dividend Indicated Gross Yield
-
Sector
Health Care
Industry
Biotech & Pharma
Sub-Industry
Biotech

Related Videos

There are currently no related videos for this ticker. Please check back later.
Profile
Repligen Corporation is a biotechnology company. The Company develops therapeutics for the treatment of diseases of the central nervous system. Repligen owns owns intellectual property on monoclonal antibody and antibody fusion products.
ADDRESS
41 Seyon Street
Building 1 Suite 100
Waltham, MA 02453
United States
PHONE
1-781-250-0111
  • Tony J Hunt
    President/CEO
  • Jon K Snodgres
    Chief Financial Officer
  • James R Rusche
    Senior VP:Research & Dev
  • Howard Benjamin
    VP:Business Development
  • Sondra S Newman
    Senior Dir:Investor Relations
Show More